Reaction bonding of silicon carbides by Binder Jet 3D-Printing, phenolic resin binder impregnation and capillary liquid silicon infiltration by Fleisher, A., Zolotaryov, D., Kovalevsky, A., Muller-Kamskii, G., Eshed, E., Kazakin, M., Popov, V.V.

Get full text

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours by Papadopoulos, K P, El-Rayes, B F, Tolcher, A W, Patnaik, A, Rasco, D W, Harvey, R D, LoRusso, P M, Sachdev, J C, Abbadessa, G, Savage, R E, Hall, T, Schwartz, B, Wang, Y, Kazakin, J, Shaib, W L

Get full text

Pharmacologic Risk Factors for Post-Operative Delirium in Total Joint Arthroplasty Patients: A Case–Control Study by Nandi, Sumon, MD, Harvey, William F., MD, MSc, Saillant, Jason, MD, Kazakin, Anatoly, BA, Talmo, Carl, MD, Bono, James, MD

Get full text

Magnetron sputtered TiO2 with metal NPs for plasmonic applications by Konev, D, Kazakin, A, Vorobyev, A, Enns, Y, Kuznetsov, A, Kondrateva, A, Mishin, M

Get full text

Optical properties of plasmonic metal nanoparticles on GaN surface by Alay, P, Enns, Y, Kazakin, A, Mizerov, A, Nikitina, E, Kondrateva, A, Vyacheslavova, E, Karaseov, P, Mishin, M

Get full text

Study of the optical properties of a NiO/AuNP/NiO nanocomposite film transferred onto a transparent flexible substrate by Enns, Y, Kondrateva, A, Komarevtsev, I, Kazakin, A, Vyacheslavova, E, Kuznetsov, A, Andreeva, V D, Mishin, M

Get full text

Electrooptical Properties of TiO2 Doped with Gold Nanoparticles by Kondrateva, A., Enns, Ya, Kazakin, A., Kleimanov, R., Morozov, I., Karaseov, P., Mishin, M.

Get full text

Magnetron sputtered TiO 2 with metal NPs for plasmonic applications by Konev, D, Kazakin, A, Vorobyev, A, Enns, Y, Kuznetsov, A, Kondrateva, A, Mishin, M

Get full text

Electrooptical Properties of TiO.sub.2 Doped with Gold Nanoparticles by Kondrateva, A, Enns, Ya, Kazakin, A, Kleimanov, R, Morozov, I, Karaseov, P, Mishin, M

Get full text

Implantable optical-electrode device for stimulation of spinal motoneurons by Matveev, M V, Erofeev, A I, Zakharova, O A, Pyatyshev, E N, Kazakin, A N, Vlasova, O L

Get full text

389 A phase 1, dose-escalation, first-in-human study of ARQ 087, an oral pan-FGFR inhibitor, in adult subjects with advanced solid tumors by Papadopoulos, K, Tolcher, A, Kittaneh, M, Patniak, A, Rasco, D, Chambers, G, Newth, G, Savage, R, Hall, T, Schwartz, B, Kazakin, J, LoRusso, P

Get full text